Share this Article
Ang CY, Yew A, Tay D, Chia SL, Yeo SJ, Lo NN, Chin PL
Correspondence: Dr Ang Chay-You, angchayyou@msn.com
ABSTRACT
INTRODUCTION The Singapore General Hospital Bone Bank, which exclusively stores femoral head allografts, relies on flash sterilisation to prevent allograft-related disease transmission and wound infection. However, intraosseous temperatures during autoclaving may be lower than required to eliminate human immunodeficiency virus, and hepatitis B and C viruses. The aim of this study is to determine the intraosseous temperatures of femoral head allografts during autoclaving and to assess the adequacy of autoclaving in preventing disease transmission.
METHODS Six femoral heads were acquired from patients who underwent hip arthroplasty. The specimens were divided into two groups. The first group underwent flash sterilisation with a sterilisation time of 4 min, while a longer sterilisation time of 22 min was used for the second group.
RESULTS The highest core temperature in the first group was 130°C, while the core temperatures in the second group plateaued at 133°C for all allografts. In the first group, only smaller allografts maintained temperatures sufficient for the inactivation of the clinically relevant viral pathogens. In contrast, all allografts in the second group were terminally sterilised.
CONCLUSION There is an inverse correlation between the size of allografts and intraosseous temperatures achieved during autoclaving. Therefore, we recommend dividing large allografts into smaller pieces, in order to achieve intraosseous temperatures adequate for the elimination of transmissible pathogens during flash sterilisation. Allografts should not be terminally sterilised, as the resulting allografts will become unusable. Despite modern processing techniques, stringent donor selection remains vital in the effort to prevent allograft-related infections. Autoclaving is an economical and efficacious method of preventing allograft-related disease transmission.
Keywords: allografts, autoclaving, bone bank, disease transmission, femoral heads
Singapore Med J 2014; 55(10): 526-528; http://dx.doi.org/10.11622/smedj.2014135
REFERENCES
| 1. Khan SN, Cammisa FP Jr, Sandhu HS, et al. The biology of bone grafting. J Am Acad Orthop Surg 2005; 13:77-86. PMid:15712985 | ||||
| 2. Younger EM, Chapman MW. Morbidity at bone graft donor sites. J Orthop Trauma 1989; 3:192-5. http://dx.doi.org/10.1097/00005131-198909000-00002 | ||||
| 3. Zwitser EW, Jiya TU, George Licher H, van Royen BJ. Design and management of an orthopaedic bone bank in The Netherlands. Cell Tissue Bank 2012; 13:63-9. http://dx.doi.org/10.1007/s10561-010-9230-4 | ||||
| 4. Galia CR, Moreira LF. The Biology of Bone Grafts. In: Fokter SK, ed. Recent Advances in Arthroplasty. InTech, 2012. | ||||
| 5. Ang CY, Loh DS, Chaw HW, Chin PL. Simple novel bone bank storage: the Singapore General Hospital experience. Biopreserv Biobank 2012; 10:526-8. http://dx.doi.org/10.1089/bio.2012.0048 | ||||
| 6. Böhm P, Stihler J. Intraosseous temperature during autoclaving. J Bone Joint Surg Br 1995; 77:649-53. PMid:7615615 | ||||
| 7. Rutala WA, Weber DJ, Healthcare Infection Control Practices Advisory Committee (HICPAC). Guideline for Disinfection and Sterilization in Healthcare Facilities, 2008. USA: Centers for Disease Control and Prevention, 2008. PMCid:PMC2600382 | ||||
| 8. Simonds RJ, Holmberg SD, Hurwitz RL, et al. Transmission of human immunodeficiency virus type 1 from a seronegative organ and tissue donor. N Engl J Med 1992; 326:726-32. http://dx.doi.org/10.1056/NEJM199203123261102 | ||||
| 9. Centers for Disease Control and Prevention (CDC). Hepatitis C virus transmission from an antibody-negative organ and tissue donor--United States, 2000-2002. MMWR Morb Mortal Wkly Rep 2003; 52:273-4, 276. PMid:12729075 | ||||
| 10. Kobayashi H, Tsuzuki M, Koshimizu K, et al. Susceptibility of hepatitis B virus to disinfectants or heat. J Clin Microbiol 1984; 20:214-6. PMid:6436295 PMCid:PMC271289 | ||||
| 11. Charm SE, Landau S, Williams B, et al. High-temperature short-time heat inactivation of HIV and other viruses in human blood plasma. Vox Sang 1992; 62:12-20. http://dx.doi.org/10.1111/j.1423-0410.1992.tb01160.x | ||||
| 12. Song H, Li J, Shi S, et al. Thermal stability and inactivation of hepatitis C virus grown in cell culture. Virol J 2010; 7:40. http://dx.doi.org/10.1186/1743-422X-7-40 | ||||